logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xinzhao Wang

breast cancer center
H指数:16
被引数:727

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Vonoprazan and High-Dose Amoxicillin Dual Therapy for Rescue Treatment of Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

伏诺拉生与高剂量阿莫西林双联疗法对幽门螺杆菌感染补救治疗的疗效与安全性：一项多中心随机对照试验

United European Gastroenterology Journal
IF6.7
2025-06-210
OAAI
Ju Zhang; Xinzhao Wang; Shujie Song; Xiaoming Zhu; Ting Lv; Lingling Wang; Lei Lei; Yuhui Wang; Yali Lei; Yating Wang; Xiaojing Zhu; Lifeng Zhang; Min Chen; Yongquan Shi
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial

既往接受过曲妥珠单抗辅助和/或新辅助治疗的患者中，吡托替尼联合白蛋白结合型紫杉醇一线治疗HER2-positive转移性乳腺癌的疗效和安全性: 单臂2期前瞻性临床试验的1期结果

CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2024-05-130
OAAI
Man, Xiaochu; Huang, Jie; Sun, Shujuan; Zhou, Dongdong; Zhang, Baoxuan; Fang, Shu; Zheng, Fangchao; Li, Chao; Wang, Xinzhao; Huang, Wei; Wang, Linlin; He, Qingqing; Fu, Hui; Zhang, Yan; Liu, Changrui; Dong, Lin; Zhao, Xianguang; Xu, Liang; Sun, Xiao; Fan, Bingjie; Song, Lihua; Zhou, Zhengbo; Yu, Jinming; Li, Huihui
Efficacy, safety and translational study of pyrotinib combined with albuminbound paclitaxel as firstline treatment of HER-2 positive metastatic breast cancer
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Li, Huihui; Man, Xiaochu; Yin, Sha; Zhou, Dongdong; Zhang, Baoxuan; Fang, Shu; Zheng, Fangchao; Li, Chao; Wang, Xinzhao; Huang, Wei; Wang, Linlin; He, Qingqing; Fu, Hui; Zhang, Yan; Liu, Changrui; Dong, Lin; Zhao, Xianguang; Xu, Liang; Sun, Xiao; Fan, Bingjie; Song, Lihua; Zhou, Zhengbo; Tan, Qiaorui
Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Li, Huihui; Zhou, Dongdong; Yv, Zeshun; Liao, Yuqian; Huang, Jie; Sun, Shujuan; Zheng, Fangchao; Li, Baojiang; Fang, Shu; Qiang, Ling; Ren, Guohua; Bu, Bing; Qiu, Pengfei; Wang, Xinzhao; Li, Chao; Cao, Fangli; Shao, Qian; Han, Dali; Song, Lihua; Zhang, Baoxuan; Fan, Bingjie; Xu, Liang; Xie, Xuemei; Zhao, Xianguang; Liu, Lanping; Li, Wanlong; Wang, Zhenbo; Liu, Changmin; Fu, Hui; Sun, Xiao; Shi, Zhiqiang; Li, Fengxiang
Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Li, Huihui; Tan, Qiaorui; Sun, Shujuan; Zhou, Dongdong; Yu, Bo; Su, Mu; Li, Baojiang; Fang, Shu; Qiang, Ling; Ren, Guohua; Bu, Bing; Yin, Sha; Man, Xiaochu; Qiu, Pengfei; Wang, Xinzhao; Li, Chao; Cao, Fangli; Shao, Qian; Han, Dali; Song, Lihua; Fan, Bingjie; Zhang, Baoxuan; Xu, Liang; Zhao, Xianguang; Liao, Yuqian; Xie, Xuemei; Liu, Lanping

研究方向

暂未获取到该数据
Z
Zhiyong Yu
H 指数:27论文数:183被引数:2,964
Z
Zhaoyun Liu
H 指数:28论文数:260被引数:3,108
F
Fukai Wang
H 指数:16论文数:66被引数:727
李
李超
H 指数:19论文数:99被引数:1,144
B
Baoxuan Zhang
H 指数:8论文数:41被引数:314
L
Lihua Song
H 指数:5论文数:28被引数:61
李超 封面图
李超
H 指数:14论文数:81被引数:544
S
Shujuan Sun
H 指数:3论文数:8被引数:13
X
Xiaochu Man
H 指数:5论文数:20被引数:74
X
Xianguang Zhao
H 指数:13论文数:45被引数:786